FDA Approves First Nonsurgical Heart Valve for Congenital Heart Disease
The Harmony TPV System provides less invasive option to treat pulmonary regurgitation in patients with native or surgically repaired right ventricular outflow tract.
Congenital Heart Disease
Atrial Switch Linked to Higher Long-Term Risk of Heart Failure and Death Risk
Risk model predicts patients at low, intermediate, and high risk for heart failure, ventricular arrhythmia, and death after atrial switch for transposition of the great arteries.
Poorer Exercise Capacity Persists With Ventricular Septal Defects
As they get older, patients with surgically closed or unrepaired congenital ventricular septal defects (VSDs) have poorer exercise capacity than their healthy peers.
Pulmonary Arterial Hypertension Associated With CHD: Developments in Treatments, Remaining Gaps According to Experts
PAH associated with CHD is linked to significant reductions in survival and quality of life, especially for patients progressing to Eisenmenger syndrome.
Udenafil NDA Submitted for Rare Congenital Heart Condition
A NDA has been submitted to the FDA for udenafil to improve the physiology of patients aged ≥12 years with single ventricle heart disease (SVHD) who have undergone the Fontan operation.
Stiffened Dilated Ascending Aorta Frequent in Repaired CHD, Associated With Reduced Exercise Capacity
Adolescents with complex congenital heart disease who have undergone surgical repair were frequently found to have a stiffened and dilated ascending aorta.
Changes Proposed for Newborn Congenital Heart Disease Screen
Changes have been suggested for the newborn critical congenital heart disease (CCHD) screening algorithm.
Impaired Cognition in Children With OSA and Congenital Heart Disease
Children with congenital heart disease and comorbid obstructive sleep apnea are at increased risk for impaired neurocognition compared with children with congenital heart disease who do not have comorbid OSA.
Effects of the Revised Pediatric Heart Allocation Policy on Waitlist Outcomes
The current pediatric heart allocation policy has increased congenital heart disease status 1A representation but has not improved waitlist mortality,
Adults With Congenital Heart Disease Hospitalized for HF at Higher Risk for AEs
Patients with congenital heart disease had higher rates of any in-hospital event, length of stay 7 days or longer, and incident arrhythmia.
-
Loading...
-
Loading...
Next post in Heart Failure
